DigestRedComo funciona
Red
/
Empresas
PO
No verificado

POXEL SA

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

17 Comunicados de prensa

Ver todos los comunicados de prensa
24/11/2025
Web y redes sociales
Biotecnología
Farmacéutica
Salud
Sanidad
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
Fuente
POXEL SA
Editor
Business Wire
1.00
0
31/10/2025
Mercado laboral
Biotecnología
Farmacéutica
Salud
Appointment of Yves Decadt as Member of Poxel’s Board of Directors
Fuente
POXEL SA
Editor
Business Wire
1.00
0
01/08/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Mercado laboral
Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance
Fuente
POXEL SA
Editor
Business Wire
1.00
0
29/07/2025
Biotecnología
Farmacéutica
Salud
Mercado laboral
Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading
Fuente
POXEL SA
Editor
Business Wire
1.00
0
30/06/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update
Fuente
POXEL SA
Editor
Business Wire
1.00
0
19/06/2025
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference
Fuente
POXEL SA
Editor
Business Wire
1.00
0
28/05/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Eventos
New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society
Fuente
POXEL SA
Editor
Business Wire
1.00
0
26/05/2025
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Cardiología
Eventos
Industria
Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025
Fuente
POXEL SA
Editor
Business Wire
1.00
0
31/03/2025
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Fuente
POXEL SA
Editor
Business Wire
1.00
0
20/03/2025
Industria
Ciencia
Cardiología
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy
Fuente
POXEL SA
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0